"10.1371_journal.pone.0053623","plos one","2013-01-07T00:00:00Z","Marta Garcia-Montojo; María Dominguez-Mozo; Ana Arias-Leal; Ángel Garcia-Martinez; Virginia De las Heras; Ignacio Casanova; Raphaël Faucard; Nadège Gehin; Alexandra Madeira; Rafael Arroyo; François Curtin; Roberto Alvarez-Lafuente; Hervé Perron","Multiple Sclerosis Unit, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain; Geneuro Innovation, Lyon, France","Conceived and designed the experiments: MGM FC HP RAL. Performed the experiments: MGM AAL AGM MDM. Analyzed the data: MGM RAL HP VDH IC RA. Contributed reagents/materials/analysis tools: RF NG AM. Wrote the paper: MGM RAL HP.","RF, NG, AM, FC and HP are employees of Geneuro and MGM received honoraria from this company for scientific consultancy. The study has been funded in part by Geneuro Innovation, a company developing therapies and diagnostic tools for diseases associated with the expression of human endogenous retroviruses, with a primary focus on the Nervous System diseases and Multiple Sclerosis. There are no patents, further products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","01","Marta Garcia-Montojo","MGM",13,TRUE,4,4,6,3,TRUE,TRUE,TRUE,1,"4",FALSE
